1 Prothrombin Complex Concentrate (PCC) Drug Market Overview
1.1 Product Overview and Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Type
1.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2023-2029)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
1.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application: (2023-2029)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Estimates and Forecasts
1.4.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue 2018-2029
1.4.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales 2018-2029
1.4.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Prothrombin Complex Concentrate (PCC) Drug Market Competition by Manufacturers
2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2018-2023)
2.4 Global Prothrombin Complex Concentrate (PCC) Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
2.7 Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends
2.7.1 Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue
2.7.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prothrombin Complex Concentrate (PCC) Drug Retrospective Market Scenario by Region
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2018-2029
3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2018-2023
3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2024-2029
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2018-2029
3.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2018-2023
3.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2024-2029
3.4 North America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.4.3 North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.5.3 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.7.1 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.7.3 Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2018-2029)
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2018-2023)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2024-2029)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2018-2029)
4.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2018-2029)
4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2018-2023)
4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2024-2029)
4.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2018-2029)
4.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2018-2029)
5.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2018-2023)
5.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2024-2029)
5.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2018-2029)
5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2018-2029)
5.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2018-2023)
5.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2024-2029)
5.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2018-2029)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL Behring GmbH
6.2.1 CSL Behring GmbH Corporation Information
6.2.2 CSL Behring GmbH Description and Business Overview
6.2.3 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.2.5 CSL Behring GmbH Recent Developments/Updates
6.3 Grifols Biologicals
6.3.1 Grifols Biologicals Corporation Information
6.3.2 Grifols Biologicals Description and Business Overview
6.3.3 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.3.5 Grifols Biologicals Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Biological
6.5.1 Hualan Biological Corporation Information
6.5.2 Hualan Biological Description and Business Overview
6.5.3 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.5.5 Hualan Biological Recent Developments/Updates
6.6 Meheco Xinxing Pharma
6.6.1 Meheco Xinxing Pharma Corporation Information
6.6.2 Meheco Xinxing Pharma Description and Business Overview
6.6.3 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.6.5 Meheco Xinxing Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis
7.2 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process
7.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing
7.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels
7.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors
7.5 Prothrombin Complex Concentrate (PCC) Drug Customers
8 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics
8.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
8.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
8.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges
8.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer